Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01905280 · ClinicalTrials.gov registry record · NA
Ridge Preservation Comparing 2 Membranes
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01905280 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 24 participants.
The verdict
NCT01905280, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical and histologic outcomes for acellular dermal matrix and a nonresorbable membrane to determine if either provides a significant therapeutic advantage. The hypothesis is that there will be no difference in crestal ridge width between the two treatments.
Interventions
- PROCEDURE Non-resorbable membrane
- PROCEDURE Acellular dermal matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01905280
The ClinicalTrials.gov registry entry for NCT01905280 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Non-resorbable membrane is the first listed.
NCT01905280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01905280 about?
NCT01905280 is a clinical study titled "Ridge Preservation Comparing 2 Membranes". The purpose of this study is to compare the clinical and histologic outcomes for acellular dermal matrix and a nonresorbable membrane to determine if either provides a significant therapeutic advantage. The hypothesis is that there will be no difference in crestal ridge width between the two treatme...
What is the current status of trial NCT01905280?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2013-09. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01905280?
The interventions under investigation include: Non-resorbable membrane (PROCEDURE), Acellular dermal matrix (PROCEDURE).
Who is sponsoring clinical trial NCT01905280?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.